STOCK-BASED COMPENSATION (Tables)
|
9 Months Ended |
Sep. 30, 2020 |
|---|
| DESCRIPTION OF BUSINESS |
|
| Schedule of Equity incentive plan |
|
|
Awards
Reserved for Issuance
|
|
|
Awards
Outstanding
|
|
|
Awards
Available
for Grant
|
|
|
|
|
|
|
|
|
|
|
|
2016 Equity incentive plan |
|
|
2,000,000 |
|
|
|
544,397 |
|
|
|
1,455,603 |
|
2018 Equity incentive plan |
|
|
43,976,425 |
|
|
|
15,055,708 |
|
|
|
28,920,717 |
|
|
| Schedule of Stock option activity |
|
|
Number of Shares |
|
|
Weighted-Average Exercise Price Per Share |
|
|
Weighted-Average Remaining Contractual Life |
|
Aggregate Intrinsic Value of In-the-Money Options |
|
|
|
|
|
|
|
|
|
|
Options outstanding as of January 1, 2020 |
|
|
12,365,295 |
|
|
$ |
0.46 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Options granted |
|
|
10,559,090 |
|
|
$ |
0.07 |
|
|
|
|
|
|
Options exercised |
|
|
- |
|
|
$ |
- |
|
|
|
|
|
|
Options forfeited |
|
|
(6,566,667 |
) |
|
$ |
1.29 |
|
|
|
|
|
|
Options expired |
|
|
(248,048 |
) |
|
$ |
1.33 |
|
|
|
|
|
|
Options outstanding as of September 30, 2020 |
|
|
16,109,670 |
|
|
$ |
0.46 |
|
|
9.0 years |
|
$ |
- |
|
Options exercisable as of September 30, 2020 |
|
|
5,593,814 |
|
|
$ |
0.91 |
|
|
8.4 years |
|
$ |
- |
|
|
| Schedule of Stock based compensation assumptions |
|
|
September 30, |
|
|
September 30, |
|
|
|
2020 |
|
|
2019 |
|
Expected term (years) |
|
6 Years |
|
|
6 Years |
|
Volatility |
|
|
104.2 |
% |
|
|
115.7 |
% |
Risk-free interest rate |
|
|
0.5 |
% |
|
|
1.9 |
% |
Dividend yield |
|
|
0 |
% |
|
|
0 |
% |
|
| Schedule of Stock-based compensation expense |
|
|
(in thousands except for shares / options) |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
For the Three Months Ended |
|
|
|
September 30, 2020 |
|
|
September 30, 2019 |
|
Type of Award |
|
Number of Shares or Options Granted |
|
|
Stock-Based Compensation Expense |
|
|
Number of Shares or Options Granted |
|
|
Stock-Based Compensation Expense |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Stock options |
|
|
909,090 |
|
|
$ |
298 |
|
|
|
143,848 |
|
|
$ |
1,078 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Stock grants: |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Employees (common stock) |
|
|
- |
|
|
|
- |
|
|
|
91,465 |
|
|
|
38 |
|
Directors (common stock) |
|
|
1,082,700 |
|
|
|
119 |
|
|
|
173,610 |
|
|
|
102 |
|
Non–employee consultants (common stock) |
|
|
84,615 |
|
|
|
11 |
|
|
|
0 |
|
|
|
0 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Total stock–based compensation expense |
|
|
|
|
|
$ |
428 |
|
|
|
|
|
|
$ |
1,218 |
|
|
|
For the Nine Months Ended |
|
|
|
September 30, 2020 |
|
|
September 30, 2019 |
|
Type of Award |
|
Number of Shares or Options Granted |
|
|
Stock-Based Compensation Expense |
|
|
Number of Shares or Options Granted |
|
|
Stock-Based Compensation Expense |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Stock options |
|
|
10,559,090 |
|
|
$ |
1,536 |
|
|
|
4,144,666 |
|
|
$ |
3,314 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Stock grants: |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Employees (common stock) |
|
|
3,179,544 |
|
|
|
58 |
(a) |
|
|
564,799 |
|
|
|
428 |
|
Directors (common stock) |
|
|
909,090 |
|
|
|
19 |
(b) |
|
|
173,610 |
|
|
|
102 |
|
Non–employee consultants (common stock) |
|
|
1,159,615 |
|
|
|
59 |
|
|
|
66,376 |
|
|
|
59 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Total stock–based compensation expense |
|
|
|
|
|
$ |
1,672 |
|
|
|
|
|
|
$ |
3,904 |
|
|